Inari Medical, Inc. (NARI)
USD 79.97
(0.0%)
USD 79.97
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 35.92 Million | -13.97 Million | 25.48 Million | 1.91 Million | -4.93 Million | -10.89 Million |
| Net Income | -1.63 Million | -29.26 Million | 9.84 Million | 13.78 Million | -1.19 Million | -10.15 Million |
| Depreciation & Amortization | 10.74 Million | 7.11 Million | 4.3 Million | 1.38 Million | 613.52 Thousand | 283 Thousand |
| Deferred income taxes | -584 Thousand | - | 47 Thousand | 4.2 Million | 1.29 Million | 144 Thousand |
| Stock-based compensation | 40.33 Million | 28.67 Million | 25.44 Million | 3.52 Million | 504.8 Thousand | 248 Thousand |
| Change in working capital | 2.63 Million | -21.46 Million | -14.3 Million | -21.16 Million | -6.25 Million | -1.52 Million |
| Other non-cash items | -15.57 Million | 973 Thousand | 143 Thousand | 181 Thousand | 101 Thousand | 106 Thousand |
| Investing Cash Flow | -58.01 Million | -195.21 Million | -51.02 Million | -55.43 Million | -3.14 Million | -753 Thousand |
| Investments in PPE | -6.2 Million | -9.95 Million | -13.64 Million | -5.46 Million | -3.14 Million | -753 Thousand |
| Acquisitions | -240.41 Million | 185.26 Million | 37.37 Million | - | - | - |
| Investment purchases | -406.73 Million | -497.86 Million | -134.37 Million | -49.97 Million | - | - |
| Sales/Maturities of investments | 595.34 Million | 312.6 Million | 97 Million | - | - | - |
| Other Investing Activities | 187.11 Million | -185.26 Million | -37.37 Million | -49.97 Million | - | - |
| Financing Cash Flow | 1.17 Million | 177.13 Million | 4.07 Million | 144.11 Million | 10.22 Million | 26.75 Million |
| Debt repayment | - | - | - | -30.25 Million | -10.14 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -9.57 Million | -6.48 Million | -2.35 Million | -25 Thousand | - | - |
| Common Stock Issuance | 10.74 Million | 183.62 Million | 6.42 Million | 164.36 Million | 127.2 Thousand | 26.93 Million |
| Other Financing Activities | 10.74 Million | 183.62 Million | 6.42 Million | 10.05 Million | 20.23 Million | 26.75 Million |
| Accounts receivables | -11.05 Million | -17.03 Million | -14.36 Million | -16.7 Million | -8.95 Million | -2.16 Million |
| Accounts payables | 344 Thousand | 1.14 Million | 3.51 Million | 498 Thousand | 1.83 Million | 372 Thousand |
| Inventory | -7.43 Million | -11.68 Million | -10.48 Million | -6.64 Million | -2.87 Million | -558 Thousand |
| Other working capital | 20.78 Million | 6.11 Million | 7.03 Million | 1.68 Million | 3.73 Million | 831 Thousand |
| Cash at beginning of period | 60.22 Million | 92.75 Million | 114.61 Million | 24.02 Million | 21.88 Million | 6.77 Million |
| Cash at end of period | 39.2 Million | 60.22 Million | 92.75 Million | 114.61 Million | 24.02 Million | 21.88 Million |
| Capital Expenditure | -6.2 Million | -9.95 Million | -13.64 Million | -5.46 Million | -3.14 Million | -753 Thousand |
| Effect of forex changes on cash | -94 Thousand | -480 Thousand | -402 Thousand | - | - | - |
| Net cash flow / Change in cash | -21.01 Million | -32.53 Million | -21.86 Million | 90.59 Million | 2.14 Million | 15.11 Million |
| Free Cash Flow | 29.72 Million | -23.92 Million | 11.84 Million | -3.54 Million | -8.08 Million | -11.64 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -18.36 Million | -31.34 Million | -24.2 Million | -1.63 Million | -4.66 Million | 3.16 Million |
| Depreciation & Amortization | 5.38 Million | 4.73 Million | 4.61 Million | 10.74 Million | 2.16 Million | 2.17 Million |
| Deferred income taxes | - | - | - | -584 Thousand | -584 Thousand | -2.27 Million |
| Stock-based compensation | 12.95 Million | 13.03 Million | 12.87 Million | 40.33 Million | 9.8 Million | 9.84 Million |
| Change in working capital | -7.22 Million | 19.02 Million | -11.35 Million | 2.63 Million | 9.54 Million | 3.02 Million |
| Other non-cash items | 9.97 Million | 32.69 Million | 6.32 Million | -15.57 Million | -4.01 Million | 10 Thousand |
| Investing Cash Flow | -34.25 Million | -5.76 Million | 39.16 Million | -58.01 Million | -59.71 Million | 11.82 Million |
| Investments in PPE | -3.7 Million | -4.58 Million | -1.91 Million | -6.2 Million | -2.4 Million | -1.6 Million |
| Acquisitions | -3.72 Million | 3.72 Million | - | -240.41 Million | -240.41 Million | -13.42 Million |
| Investment purchases | -52.04 Million | -17.53 Million | -21.5 Million | -406.73 Million | -11.67 Million | -110.33 Million |
| Sales/Maturities of investments | 21.5 Million | 12.63 Million | 62.57 Million | 595.34 Million | 194.78 Million | 123.76 Million |
| Other Investing Activities | -819 Thousand | 3.72 Million | -660 Thousand | 187.11 Million | 181.61 Million | 13.42 Million |
| Financing Cash Flow | 2.38 Million | -2.75 Million | 1.01 Million | 1.17 Million | -2.41 Million | 3.46 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 8.13 Million | -2.85 Million | 3.98 Million | -9.57 Million | -2.68 Million | -2.38 Million |
| Common Stock Issuance | -4.08 Million | 98 Thousand | 3.98 Million | 10.74 Million | 278 Thousand | 5.85 Million |
| Other Financing Activities | 2.38 Million | -2.85 Million | -3.11 Million | 10.74 Million | 278 Thousand | 5.85 Million |
| Accounts receivables | -2.78 Million | -3.64 Million | -8.67 Million | -11.05 Million | 512 Thousand | -7 Million |
| Accounts payables | -923 Thousand | 4.35 Million | 1.49 Million | 344 Thousand | -2.09 Million | 2.85 Million |
| Inventory | -5.45 Million | -4.83 Million | -2.09 Million | -7.43 Million | 359 Thousand | -1.46 Million |
| Other working capital | 1.93 Million | 23.14 Million | -2.08 Million | 20.78 Million | 10.76 Million | 8.63 Million |
| Cash at beginning of period | 70.19 Million | 67.2 Million | 39.2 Million | 60.22 Million | 89.18 Million | 57.83 Million |
| Cash at end of period | 41.2 Million | 70.19 Million | 67.2 Million | 39.2 Million | 39.2 Million | 89.18 Million |
| Capital Expenditure | -3.7 Million | -4.58 Million | -1.91 Million | -6.2 Million | -2.4 Million | -1.6 Million |
| Effect of forex changes on cash | 171 Thousand | -14 Thousand | 110 Thousand | -94 Thousand | -89 Thousand | 118 Thousand |
| Net cash flow / Change in cash | -28.98 Million | 2.98 Million | 27.99 Million | -21.01 Million | -49.97 Million | 31.34 Million |
| Free Cash Flow | -995 Thousand | 6.93 Million | -14.19 Million | 29.72 Million | 9.84 Million | 14.33 Million |
3760
TSLA
002450
002690
VTEX
7412